Informed-money record

ALKS · Alkermes plc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

0

Bearish filings

53

Named actors

12

Disclosed $ (bull / bear)

$0 / $12.4M

Recent disclosures

25 of 53 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-06EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$110KSEC ↗
2026-07-06Officer (via Merrill Lynch) Gaffin David Josephfiled notice to sell$110KSEC ↗
2026-07-01EVP R&D, Chief Medical Officer Hopkinson Craig C.sold$427KSEC ↗
2026-07-01EVP R&D, Chief Medical Officer Hopkinson Craig C.sold$36KSEC ↗
2026-07-01Officer (via Merrill Lynch) Hopkinson Craig C.filed notice to sell$464KSEC ↗
2026-06-12Director Wright Christopher Isold$90KSEC ↗
2026-06-12Officer (via Merrill Lynch) Wright Christopher Ifiled notice to sell$90KSEC ↗
2026-06-04EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$88KSEC ↗
2026-06-04Officer (via Merrill Lynch) Gaffin David Josephfiled notice to sell$88KSEC ↗
2026-06-01EVP R&D, Chief Medical Officer Hopkinson Craig C.sold$375KSEC ↗
2026-06-01Officer (via Merrill Lynch) Hopkinson Craig C.filed notice to sell$375KSEC ↗
2026-05-29VP, Finance (Interim PAO) Parisi Samuel Josephsold$687KSEC ↗
2026-05-04EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$68KSEC ↗
2026-05-04Officer (via Merrill Lynch) Gaffin David Josephfiled notice to sell$68KSEC ↗
2026-05-01EVP R&D, Chief Medical Officer Hopkinson Craig C.sold$301KSEC ↗
2026-05-01Officer (via Merrill Lynch) Hopkinson Craig C.filed notice to sell$301KSEC ↗
2026-04-06EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$70KSEC ↗
2026-04-06Officer (via Merrill Lynch) Gaffin David Josephfiled notice to sell$70KSEC ↗
2026-04-01Officer (via Merrill Lynch) Hopkinson Craig C.filed notice to sell$320KSEC ↗
2026-03-12Chairman and Chief Executive Officer Richard Popsadopted a selling planSEC ↗
2026-03-11M.D., Ph.D., a director of the Company Christopher Wrightadopted a selling planSEC ↗
2026-03-03EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$61KSEC ↗
2026-03-03Officer (via Merrill Lynch) Gaffin David Josephfiled notice to sell$61KSEC ↗
2026-03-02EVP, CLO, Alkermes, Inc. Gaffin David Josephsold$60KSEC ↗
2026-03-02EVP R&D, Chief Medical Officer Hopkinson Craig C.sold$267KSEC ↗

28 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals